| Product Name | MF | CAS | Details |
|---|
| Sirt2-IN-6 | C26H26N6O3S | 2243151-81-5 | Details |
| Nrf2 activator-5 | C25H30Cl2O6 | 1012860-13-7 | Details |
| HER2-IN-6 | C26H32N8O3 | 2691891-38-8 | Details |
| Anticancer agent 31 | C28H21F2N5O2 | 2222930-72-3 | Details |
| RyRs activator 1 | C21H14ClF3N6O4 | 2571579-14-9 | Details |
| ALK5-IN-6 | C28H36N4O5 | 2657720-04-0 | Details |
| Cap-dependent endonuclease-IN-13 | C25H20F2N4O4S | 2703046-60-8 | Details |
| HCV-IN-36 | C30H36ClN5 | 2757963-81-6 | Details |
| mGAT3/4-IN-2 | C26H32ClN3OS2 | 2556833-68-0 | Details |
| ChemR23-IN-1 | C28H29N7O2 | 2378640-10-7 | Details |
| ChemR23-IN-2 | C29H26N4O5 | 2465086-50-2 | Details |
| EGFR-IN-46 | C27H32F3N3O3 | 2764772-88-3 | Details |
| Feniralstat | C26H25F2N5O4 | 2166320-76-7 | Details |
| BCR-ABL-IN-6 | C27H22F3N5O2 | 2499499-26-0 | Details |
| HER2-IN-5 | C27H33N7O3 | 2691891-36-6 | Details |
| MALT1-IN-6 | C18H12Cl2F3N9O | 2254669-07-1 | Details |
| COX-2-IN-26 | C23H21N7OS3 | 2413565-19-0 | Details |
| HDAC-IN-45 | C25H20ClFN8O | 2421122-61-2 | Details |
| Antimalarial agent 12 | C26H18BrClN2O2 | 2715225-58-2 | Details |
| SH498 | C27H25F3N2O4 | 2125724-38-9 | Details |
| S1PR1 agonist 1 | C29H30N4O4 | 2700209-37-4 | Details |
| HDAC1-IN-4 | C21H24BrClN6O2 | 2482998-39-8 | Details |
| CB 168 | C20H30N6O7S | 1241942-59-5 | Details |
| HCV-IN-35 | C30H36ClN5 | 2757963-82-7 | Details |
| COX-2/sEH-IN-1 | C23H18F3N5O3S | 2474977-38-1 | Details |
| IRAK4-IN-8 | C23H23F2N7O2S | 2033070-97-0 | Details |
| RSV-IN-5 | C28H37N7O2 | 2415018-86-7 | Details |
| Antitubercular agent-31 | C20H24F2N4O5S2 | 2764818-29-1 | Details |
| CDK9-IN-19 | C26H22F2N4O5 | 2479306-60-8 | Details |
| DPPY | C25H26ClN7O3 | 2095883-62-6 | Details |
| Xelaglifam | C30H28FNO5 | 2230597-99-4 | Details |
| W13 | C30H34N4O3 | 1060518-03-7 | Details |
| RIPK1-IN-8 | C26H24F2N6O3 | 2319663-07-3 | Details |
| DHFR-IN-1 | C22H22N6O4S2 | 2757991-65-2 | Details |
| Antimalarial agent 15 | C29H30N2O6 | 956928-33-9 | Details |
| ACSS2-IN-1 | C27H25ClN6O2 | 2711039-08-4 | Details |
| SARS-CoV-2 3CLpro-IN-2 | C21H18F5N5O4 | 2765088-93-3 | Details |
| FtsZ-IN-1 | C26H32IN3 | 2516246-24-3 | Details |
| FtsZ-IN-2 | C30H35N5S | 2249757-45-5 | Details |
| HPK1-IN-27 | C26H23F3N4O4 | 2268794-52-9 | Details |
| BuChE-IN-4 | C21H21BrFN3O4S | 2499490-52-5 | Details |
| HIV-1 protease-IN-1 | C25H35N3O6S | 2765293-30-7 | Details |
| Apoptosis inducer 8 | C29H22ClN5O2 | 2470024-51-0 | Details |
| THR-β agonist 4 | C16H11Cl2F2N5O6S | 2673409-25-9 | Details |
| Lp-PLA2-IN-4 | C23H18F5N3O4 | 2738877-91-1 | Details |
| BCR-ABL-IN-5 | C25H21Cl2N5O2 | 1795736-60-5 | Details |
| COX-2-IN-23 | C24H25N5O3S2 | 2417995-08-3 | Details |
| Antitumor agent-71 | C26H31N5O4S | 2011756-99-1 | Details |
| INSCoV-614(1B) | C23H21ClF3N5O3 | 2735704-33-1 | Details |
| EGFR-IN-59 | C27H23N5O4S | 2529891-44-7 | Details |
| DNA Gyrase-IN-2 | C24H24N8OS2 | 2522666-80-2 | Details |
| Glucocorticoid receptor-IN-1 | C24H19F4N7O2 | 2662908-25-8 | Details |
| RET-IN-15 | C27H28N8O2 | 2643375-86-2 | Details |
| CDK7-IN-17 | C24H26F3N6OP | 2765676-60-4 | Details |
| Pan-Trk-IN-2 | C22H18ClF3N6O3 | 2583778-77-0 | Details |
| TGR5 Receptor Agonist 3 | C29H27N3O6 | 2643391-08-4 | Details |
| HDAC/Top-IN-1 | C29H25FN4O4 | 2411379-14-9 | Details |
| PI3K/Akt/mTOR-IN-3 | C34H51NO2 | 2457245-94-0 | Details |
| SHR902275 | C26H23F3N4O4 | 2695506-82-0 | Details |
| ATR-IN-6 | C28H28FN7O2 | 2746446-99-9 | Details |
| EGFR/HER2/TS-IN-2 | C26H21N7OS2 | 2444364-04-7 | Details |
| EGFR/HER2/TS-IN-1 | C24H15N5O4S2 | 2444363-11-3 | Details |
| (S,R)-WT IDH1 Inhibitor 2 | C28H28FN5O3 | 1816272-18-0 | Details |
| PARP1/BRD4-IN-1 | C29H26N6O3 | 2758117-74-5 | Details |
| Glucocorticoid receptor-IN-2 | C25H20F4N6O2 | 2664932-65-2 | Details |
| HPK1-IN-28 | C25H22F3N5O4 | 2699603-89-7 | Details |
| Dual FAAH/sEH-IN-1 | C25H22ClN3O3S2 | 2756099-59-7 | Details |
| INSCoV-601I(1) | C23H22ClF2N5O2S | 2735704-19-3 | Details |
| HDAC6-IN-4 | C30H38N2O5 | 2709103-20-6 | Details |
| Anticancer agent 77 | C25H30BrN7 | 2787582-75-4 | Details |
| Enpp-1-IN-13 | C28H22ClN5OS | 2417022-19-4 | Details |
| PI3Kδ/γ-IN-1 | C25H28N6O4S | 1980884-01-2 | Details |
| MS8511 | C28H41N5O3 | 2866408-21-9 | Details |
| Ulecaciclib | C25H33FN8S | 2075750-05-7 | Details |
| WT IDH1 Inhibitor 2 | C28H28FN5O3 | 1816272-19-1 | Details |
| HDAC6/HSP90-IN-1 | C28H37N3O6 | 2411955-43-4 | Details |
| STING agonist-10 | C25H20ClF4N3O2 | 2259308-69-3 | Details |
| INSCoV-600K(1) | C23H22ClF2N5O2S | 2735704-15-9 | Details |
| hA2A/hCA XII modulator 1 | C24H19N7O4S | 2548963-55-7 | Details |
| Antiplatelet agent 1 | C21H24F2N6O4S | 2493297-12-2 | Details |
| mGAT3/4-IN-1 | C26H31ClN2O2S2 | 2556833-57-7 | Details |
| Antiplatelet agent 2 | C21H24F2N6O4S | 1395047-93-4 | Details |
| CCG-273220 | C26H24ClFN4O3 | 2750414-35-6 | Details |
| Antibacterial agent 67 | C24H15F6N5O | 2488900-01-0 | Details |
| SARS-CoV-2 3CLpro-IN-1 | C27H30ClN3O3S | 2757970-20-8 | Details |
| TRK-IN-18 | C25H23F2N5O2S | 2412008-91-2 | Details |
| ERCC1-XPF-IN-1 | C28H32ClN5O2 | 2411584-25-1 | Details |
| DNA Gyrase-IN-5 | C25H15BrClN5 | 2417016-23-8 | Details |
| Antitumor agent-60 | C24H28O10S | 865784-65-2 | Details |
| STING agonist-11 | C25H20ClF4N3O2 | 2259308-68-2 | Details |
| OM-153 | C28H24FN7O2 | 2406278-81-5 | Details |
| HDAC/HSP90-IN-3 | C26H33N5O6 | 2700035-54-5 | Details |
| BRP-201 | C28H27ClN4OS | 2227434-74-2 | Details |
| Antimycobacterial agent-2 | C31H50O5 | 62670-49-9 | Details |
| CS12192 | C25H23ClFN7O2 | 1888318-68-0 | Details |
| CDK7-IN-8 | C25H38N8O3 | 2654003-64-0 | Details |
| Lp-PLA2-IN-5 | C23H18F5N3O4 | 2738877-85-3 | Details |
| Tau-aggregation-IN-1 | C28H37N5O2S | 1619269-19-0 | Details |
| PDGFRα/FLT3-ITD-IN-1 | C27H39N9O | 2761259-05-4 | Details |
| EGFR/HER2/CDK9-IN-2 | C23H20N4O5S2 | 1180924-34-8 | Details |
| Product Total： Product Page： | ||||
| 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 | ||||